The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Toxoplasma gondii Infection in Immunocompromised Patients: A Systematic Review and Meta-Analysis
Open accessAbstract
Toxoplasma gondii has been suggested as an important opportunistic pathogen in immunocompromised patients. We conducted a global meta-analysis to assess the prevalence and odds ratios (ORs) of T. gondii infection in immunocompromised individuals. Electronic databases were reviewed for T. gondii infection in HIV/AIDS patients, cancer patients, and transplant recipients, and meta-analyses were conducted to calculate overall estimated prevalence and ORs using random-effects models. Totally, 72 eligible studies were included. The estimated pooled prevalence of T. gondii infection in immunocompromised patients and the control was 35.9% and 24.7% (p0.05), whose estimated pooled ORs were 2.03, 2.89, and 1.51 (95% CI, 1.16–1.95), respectively. This study is the first to demonstrate that the immunocompromised patients are associated with higher odds of T. gondii infection, and appropriate prevention and control measures are highly recommended for these susceptible populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
A basic introduction to fixed-effect and random-effects models for meta-analysis
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2010) · Research Synthesis Methods · doi:10.1002/jrsm.12 · Cited by 6,793 · cited 2×
“The following information was extracted from each study: first author, publication year, country of the study, the number of patients and control, diagnostic methods, and demographic characteristics.”
MethodMontoya, J., & Liesenfeld, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16412-x · Cited by 3,232
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
Robert-Gangneux, F., & Dardé, M.-L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05013-11 · Cited by 1,815
Waterborne transmission of protozoan parasites: Review of worldwide outbreaks - An update 2011–2016
Efstratiou, A., Ongerth, J. E., & Karanis, P. (2017) · Water Research · doi:10.1016/j.watres.2017.01.036 · Cited by 1,106
Strunz, E. C., Addiss, D. G., Stocks, M. E., Ogden, S., Utzinger, J., & Freeman, M. C. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001620 · Cited by 795
Waterborne transmission of protozoan parasites: Review of worldwide outbreaks – An update 2004–2010
Baldursson, S., & Karanis, P. (2011) · Water Research · doi:10.1016/j.watres.2011.10.013 · Cited by 789
Diagnosis of toxoplasmosis and typing of Toxoplasma gondii
Liu, Q., Wang, Z.-D., Huang, S.-Y., & Zhu, X.-Q. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-0902-6 · Cited by 529
Self-citationA review on human toxoplasmosis
Saadatnia, G., & Golkar, M. (2012) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2012.693197 · Cited by 417
Toxoplasmic Encephalitis in Patients with the Acquired Immunodeficiency Syndrome
Luft, B. J., Hafner, R., Korzun, A. H., Leport, C., Antoniskis, D., Bosler, E. M., Bourland, D. D., Uttamchandani, R., Fuhrer, J., Jacobson, J., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291403 · Cited by 405
Liu, S., Zhang, H., Gu, C., Yin, J., He, Y., Xie, J., & Cao, G. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp180 · Cited by 388
Serologic and Immunologic Studies in Patients With AIDS in North America and Africa
Quinn, T. C. (1987) · JAMA · doi:10.1001/jama.1987.03390190095027 · Cited by 230
Sharma, S. D., Mullenax, J., Araujo, F. G., Erlich, H. A., & Remington, J. S. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.2.977 · Cited by 227
Speich, B., Croll, D., Fürst, T., Utzinger, J., & Keiser, J. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00349-7 · Cited by 163
Cong, W., Liu, G., Meng, Q.-F., Dong, W., Qin, S., Zhang, F.-K., Zhang, X., Wang, X., Ai-dong, Q., & Zhu, X. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.036 · Cited by 150
Self-citationParasitic Central Nervous System Infections in Immunocompromised Hosts
Walker, M., & Zunt, J. R. (2005) · Clinical Infectious Diseases · doi:10.1086/428621 · Cited by 149
Simporè, J., Savadogo, A., Ilboudo, D. P., et al. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20615 · Cited by 119
Importance of Nonenteric Protozoan Infections in Immunocompromised People
Barratt, J., HARKNESS, J., Marriott, D., Ellis, J., & Stark, D. J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-10 · Cited by 99
Walle, F., Kebede, N., Tsegaye, A., & Kassa, T. (2013) · Parasites & Vectors · doi:10.1186/1756-3305-6-15 · Cited by 92
A systematic review and meta-analysis of Toxoplasma gondii infection among the Mexican population
Galván-Ramírez, M. D. L. L., Troyo, R., Román, S., et al. (2012) · Parasites & Vectors · doi:10.1186/1756-3305-5-271 · Cited by 84
Tumours of the Brain and Presence of Antibodies to Toxoplasma gondii
Ryan, P., Hurley, S. F., Johnson, A. M., et al. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.3.412 · Cited by 70
Štajner, T., Vasiljevic, Z. V., Vujić, D., Marković, M., Ristić, G., Mićić, D., Pašić, S., Ivović, V., Ajzenberg, D., & Djurković–Djaković, O. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01077-13 · Cited by 62
Investigation of anti-Toxoplasma gondii antibodies in patients with neoplasia
Yazar, S., Yaman, O., Eser, B., et al. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45587-0 · Cited by 60
HUMAN TOXOPLASMOSIS OUTBREAKS AND THE AGENT INFECTING FORM. FINDINGS FROM A SYSTEMATIC REVIEW
Meireles, L. R., Ekman, C. C. J., de Andrade, H. F., & Luna, E. J. D. A. (2015) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652015000500001 · Cited by 59
Preliminary report of HIV and Toxoplasma gondii occurrence in pregnant women from Mozambique
Sitoe, S. P. B. L., Rafael, B., Meireles, L. R., et al. (2010) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652010000600002 · Cited by 43
Sluiters, J. F., Balk, A. H. M. M., Essed, C. E., et al. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.3.529-535.1989 · Cited by 36
Akanmu, S. A., Osukalu, V. O., Osunkalu, V. O., et al. (2010) · Nigerian Quarterly Journal of Hospital Medicine · doi:10.4314/nqjhm.v20i1.57974 · Cited by 27
Toxoplasma gondii myelitis in a patient with adult T-cell leukemia-lymphoma
Maciel, E. A. P., de Siqueira, I. C., de Queiroz, A. C., & Melo, A. D. S. (2000) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2000000600019 · Cited by 23
Hamza, H., El-Taweel, H. A., & Abou-Holw, S. A. (2015) · Journal of the Egyptian Society of Parasitology · doi:10.12816/0010844 · Cited by 9
Bashiri, H., Sayad, B., & Madani, S. H. (2013) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.4828 · Cited by 8
Cited by
The One Health Approach to Toxoplasmosis: Epidemiology, Control, and Prevention Strategies
Aguirre, A. A., Longcore, T., Barbieri, M., Dabritz, H., Hill, D., Klein, P. N., Lepczyk, C., Lilly, E. L., McLeod, R., Milcarsky, J., et al. (2019) · EcoHealth · doi:10.1007/s10393-019-01405-7 · Cited by 315
Control of human toxoplasmosis
Smith, N. C., Goulart, C., Hayward, J. A., Kupz, A., Miller, C. M., & van Dooren, G. G. (2021) · International Journal for Parasitology · doi:10.1016/j.ijpara.2020.11.001 · Cited by 286
Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis
Elsheikha, H. M., Marra, C. M., & Zhu, X.-Q. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00115-19 · Cited by 262
Self-citationPromising drug targets and compounds with anti-Toxoplasma gondii activity
Silva, M. D., Teixeira, C., Gomes, P., & Borges, M. (2021) · Microorganisms · doi:10.3390/microorganisms9091960 · Cited by 44
Zheng, B., Lou, D., Ding, J., Zhuo, X., Ding, H., Kong, Q., & Lu, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00418 · Cited by 37
Metadata
- Authors
- Wang, Z.-D., Liu, H.-H., Ma, Z.-X., Ma, H.-Y., Li, Z.-Y., Yang, Z.-B., Zhu, X.-Q., Xu, B., Wei, F., & Liu, Q.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2017-03-09
- Volume
- 8
- Pages
- 389-389
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2591809707
- Cited by
- 311
- References
- 34
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.